James Udelson, MD, Interim Chief Physician Executive of The CardioVascular Center and Chief of the Division of Cardiology at Tufts Medical Center, in an article and a press release about Alleviant Medical gaining FDA approval for a new clinical trial and breakthrough designation for its new heart failure therapy.